ストックスクリーナーアプリを入手
0.5017
5.38%
-0.0285
アフターアワーズ：
.53
0.0283
+5.64%
Century Therapeutics Inc (IPSC) 最新ニュース
Is it possible to buy Century Therapeutics Inc(IPSC) shares at a good price now? - uspostnews.com
Century Therapeutics Inc (IPSC): A Sitting Duck With -825.93% Upside Potential - Stocksregister
H.C. Wainwright maintains Buy rating on Century Therapeutics stock - Investing.com
Century Therapeutics Inc (IPSC)’s financial ratios: A comprehensive overview - DWinneX
H.C. Wainwright maintains Buy rating on Century Therapeutics stock By Investing.com - Investing.com UK
Century Therapeutics Inc [IPSC] Stock sold by Insider Pfeiffenberger Brent for $1375.0 - knoxdaily.com
Century Therapeutics Hosts Live Fireside Chat on Groundbreaking Cell Therapy Advances - MSN
Century Therapeutics to Host Live Chat on Preclinical Cell Therapy Programs Targeting Autoimmune Diseases and Cancer - Nasdaq
Century Therapeutics to Host Live Fireside Chat Focused on - GlobeNewswire
Century Therapeutics Unveils Next-Gen Cell Therapy Pipeline for Cancer and Autoimmune | IPSC Stock News - Stock Titan
American Century Companies Inc. Buys Shares of 105,337 Sangamo Therapeutics, Inc. (NASDAQ:SGMO) - Defense World
American Century Companies Inc. Buys 24,153 Shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI) - Defense World
American Century Companies Inc. Purchases 12,162 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World
American Century Companies Inc. Invests $231,000 in Summit Therapeutics Inc. (NASDAQ:SMMT) - Defense World
Sei Investments Co. Purchases New Stake in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World
American Century Companies Inc. Invests $570,000 in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - Defense World
American Century Companies Inc. Boosts Holdings in C4 Therapeutics, Inc. (NASDAQ:CCCC) - Defense World
American Century Companies Inc. Invests $474,000 in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
American Century Companies Inc. Acquires 4,547 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World
American Century Companies Inc. Purchases 13,916 Shares of Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World
American Century Companies Inc. Has $696,000 Stock Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Shares Bought by American Century Companies Inc. - Defense World
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Purchased by American Century Companies Inc. - Defense World
American Century Companies Inc. Buys 24,090 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - Defense World
HC Wainwright Issues Positive Forecast for IPSC Earnings - Defense World
American Century Companies Inc. Acquires 39,932 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World
American Century Companies Inc. Has $3.36 Million Stock Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM) - Defense World
American Century Companies Inc. Buys 1,622 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World
Century Therapeutics Partners with Experts for New Trial on Autoimmune Diseases - MSN
American Century Companies Inc. Purchases 31,251 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World
HC Wainwright Issues Pessimistic Forecast for Century Therapeutics (NASDAQ:IPSC) Stock Price - Defense World
H.C. Wainwright cuts Century Therapeutics target to $2 By Investing.com - Investing.com Canada
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Shares Sold by American Century Companies Inc. - Defense World
American Century Companies Inc. Raises Position in Denali Therapeutics Inc. (NASDAQ:DNLI) - Defense World
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by American Century Companies Inc. - Defense World
Guggenheim Reiterates Buy Rating for Century Therapeutics (NASDAQ:IPSC) - Defense World
What is Chardan Capital’s Estimate for IPSC FY2025 Earnings? - Defense World
Century Therapeutics (IPSC) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Century Therapeutics (NASDAQ:IPSC) Price Target Lowered to $7.00 at Chardan Capital - Defense World
William Blair Issues Optimistic Forecast for IPSC Earnings - The AM Reporter
Carnival To Rally Around 48%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Q1 EPS Estimate for Century Therapeutics Boosted by Analyst - Defense World
Chardan Cuts Price Target on Century Therapeutics to $7 From $11, Keeps Buy Rating - MarketScreener
Century Therapeutics Announces Strategic Pipeline Shift and 2024 Financial Results - MSN
Guggenheim Lowers Century Therapeutics (NASDAQ:IPSC) Price Target to $5.00 - Defense World
Piper Sandler Cuts Century Therapeutics (NASDAQ:IPSC) Price Target to $2.00 - Defense World
Guggenheim cuts Century Therapeutics target to $5, keeps Buy rating By Investing.com - Investing.com Canada
What is William Blair’s Estimate for IPSC Q3 Earnings? - Defense World
Demystifying Century Therapeutics: Insights From 4 Analyst Reviews - Benzinga
Century Therapeutics Reports 2024 Financial Results and Strategic Updates - TipRanks
Leerink Partners Adjusts Price Target on Century Therapeutics to $8 From $13, Keeps Outperform Rating - Marketscreener.com
Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Schedules First Quarter 2025 Conference Call for May 6, 2025 - The Manila Times
Century Therapeutics, Inc. (IPSC) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Century Therapeutics, Inc. SEC 10-K Report - TradingView
Century Therapeutics Announces Pipeline Re-Prioritization to Focus on Transformational Programs and Extends Cash Runway into Q4 2026 - Nasdaq
Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire
0.24%
36.06%
大文字化:
|
ボリューム (24 時間):